1. FM-WEBSITE

Search Page

[current-page:query:search_api_aggregation_1]

Filter and Sort

Content type

651 - 660 of 2170
Paper

The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

António Almeida 2019. LEUKEMIA
Paper

Genetic variability of influx and efflux transporters: the impact on susceptibility to chronic myeloid leukemia development

António Almeida 2019. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Paper

The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study

António Almeida 2018. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Paper

IMPACT OF GENE MUTATIONS ON RESPONSE TO LENALIDOMIDE AND OS IN LOWER-RISK NON-DEL(5Q) MDS PATIENTS INELIGIBLE/REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)

António Almeida 2017. HAEMATOLOGICA
Paper

CHRONIC MYELOID LEUKEMIA PATIENTS WERE NOT DIFFERENT IN MOLECULAR RELAPSE AFTER STOPPING IMATINIB IN MR4 WHETHER RESIDUAL DISEASE WAS DETECTED OR NOT - WHEN ADJUSTING FOR NUMBER OF CONTROL TRANSCRIPTS

António Almeida 2017. HAEMATOLOGICA